Tommaso Croaza
Dr. Tommaso Croaza is a clinical researcher who has worked alongside Professor Michal Schwartz in the development of novel therapeutic approaches for Alzheimer's disease. As the Vice President of Clinical Development at Immunobrain, he plays a crucial role in translating innovative research into clinical practice, focusing on improving treatment outcomes for patients with neurodegenerative disorders.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| Israel | 1 | 7.00 | 0.09% | +0% | 9,216,900 | 8,687 | $400,000 | 377$ |
| Totals | 1 | 9,216,900 | 8,687 | $400,000 | 377$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Israel:
Dr. Tommaso Croaza, a former doctoral student in Prof. Schwartz's lab, is now the Vice President of Clinical Development at Immunobrain.
7